StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)

Close on Nov 17, 2026Market cap $88.39MP/E –Yield –

Stereotaxis EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Stereotaxis

Stereotaxis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Stereotaxis figures

See a number that looks wrong?